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The success of cancer treatments have resulted in a rapid growth of survivors, providing 
the impetus for the oncology community to examine models of care supporting smooth 
transition from active treatment to survivorship care. While initially a recommendation of 
the Institute of Medicine, treatment summaries and survivorship care plans are now an 
accreditation requirement for many organizations. This article describes the 
implementation of an evidence based practice project designed to meet these standards 
while improving the knowledge and satisfaction of a population of breast cancer patients 
at a community-based oncology practice. 
Background 
 Today, an estimated 14.5 million people are survivors of cancer, and the number 
is steadily rising due to dramatic and rapid advances in the screening, diagnosis, and 
treatment of cancer.1,2 Breast cancer survivors are a prominent subset, accounting for 3.1 
million survivors.3 Projections are that 68% of adults with cancer are expected to be alive 
in 5 years, a remarkable upward trend from 1977 when the 5-year survival rate was a 
mere 49%.1 Regarding breast cancer, a woman diagnosed today, has an 89% chance of 
being alive in 5-years, 83% in 10 years, and 78% at 15 years.2 
These expanding categories of patients, those presumed cured, and those living 
with cancer as a chronic disease, present a new dilemma in the paradigm of cancer care. 
Oncology providers are taxed with evaluating the evidence of a rapid expansion of fast-
tracked chemotherapeutics, biologic agents, and immunotherapies and how to best 
sequence therapy.  The demand to keep pace in the area of acute oncology has 
overshadowed the growing concerns on both ends of the spectrum of oncology care: 
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those who survive their disease and those who will succumb. The evaluation and 
implementation of care models to transfer these responsibilities to other qualified 
providers is a vexing challenge. 
In the 2006 Institute of Medicine (IOM) Report, From Cancer Patient to Cancer 
Survivors: Lost in Transition, survivorship care was described as falling short of the ideal 
being plagued with poor communication, fragmentation, and lack of coordination of 
services. Inappropriate use of services, lack of attention to late- and long-term effects, 
and the absence of preventive care were also cited.4 A major limitation of their 
survivorship care reported by patients was insufficient communication between their 
oncologist and primary care provider (PCP), leading to feelings of anxiety and 
abandonment.5,6 A significant proportion of PCPs, 84%, report being uncertain of the 
frequency and type of surveillance tests they should be ordering.7 Critical to monitoring 
survivors of cancer, is understanding the long-term side effects of the drugs and treatment 
modalities employed.8 In the 2009 Survey of Physician Attitudes Regarding the Care of 
Cancer Survivors, of the 1072 PCPs who responded, only 6% were able to identify the 
four most common late adverse effects of the four most commonly used 
chemotherapeutics.9 
 Of the 10 recommendations for improving the care of survivors cited by the IOM, 
only recommendation two:  “Patients completing primary treatment should be provided 
with a comprehensive care summary and follow–up plan…4” was concrete, and clearly 
directed to providers of oncology care. 
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Current cancer treatment modalities save many more lives then in the past but 
have considerable consequences and are far from benign.10,11 The cancer experience does 
not culminate upon the completion of treatment and most survivors are left with physical 
and psychosocial lasting and latent effects.10,12 Survivorship is a distinct phase in the 
trajectory of the cancer experience.4 Studies of survivors report more then 25 problems 
and needs following treatment including fatigue, sleep deprivation, pain, depression, 
anxiety, and fear of recurrence.4,6,10,13 Survivors of breast cancer also express concerns of 
weight gain, skin changes, pain, lymphedema, cognitive impairment, and for those with 
hereditary breast cancer syndromes, risk to family members.4,10,13,14 Side effects of 
estrogen deprivation: hot flashes, vaginal dryness, premature menopause, infertility, and 
risk of osteoporosis also affect quality of life.4,13 For breast cancer survivors, high levels 
of stress and feeling uninformed on the persistent side effects of cancer treatment give 
rise to feelings of isolation, anxiety, and depression.6,15  
Cancer survivors have more co-morbidities and chronic health problems then the 
general population, and are at risk for receiving inadequate health care.6,12 At the 
conclusion of active treatment, survivors report wanting more information about their 
diagnosis, treatment, long-term side effects, risk of recurrence, and health maintenance.6 
As the immediate crisis of diagnosis and treatments wanes, insurance issues, occupational 
concerns, medical bills, and relational issues become paramount as the survivors begin 
the process of finding their “new normal”.6,16  
Treatment summaries and survivorship care plans (TS/SCP) were designed to 
synopsize the modalities used in treating a patient’s cancer, and as a guideline for follow-
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up care.4 The provision of a TS/SCPs and survivorship care is now a core measure of the 
American College of Surgeons Commission on Cancer (CoC), American Society of 
Clinical Oncology Quality Oncology Practice Initiative (ASCO QOPI®), and the 
National Accreditation Program for Breast Centers (NAPBC).17–19 Presently, only 43% of 
the National Cancer Institute (NCI) designated cancer centers provide TS/SCPs for breast 
and/or colorectal cancer survivors.7 A national survey of 1130 medical oncologists 
reported always/almost always discussing some aspect of survivorship care 64% of the 
time; however, less then 10% report consistently providing a written TS/SCP.20  
Practice Innovation 
Aim 
The purpose of this evidence-based practice project (EBP) was to incorporate a 
TS/SCP for women completing adjuvant treatment for breast cancer that would enhance 
their knowledge and satisfaction with care. The TS/SCP and survivorship visit were 
designed to provide clarity to the breast cancer survivor on the frequency and purpose of 
the follow-up visits, and to educate on the possible long- and late effects of treatment, 
assess risk factors, and teach healthy behaviors to minimize recurrence and secondary 
cancers. An additional goal was to disseminate this information to the providers involved 
in the patient’s ongoing care.  
Local Problem and Setting 
California Cancer Associates for Research and Excellence (cCARE) is a 
community-based, multi-location, large oncology hematology practice located in 
Southern and Central California. This practice innovation was incorporated in a single 
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office setting with two full time oncologists, along with one full time, and one part time 
Nurse Practitioner (NP). 
At the start of treatment, significant time and resources are allocated in preparing 
the patient for chemotherapy through a formal, standardized chemotherapy-teaching 
protocol. At the completion of adjuvant chemotherapy, no formal visits or written 
materials addressing survivorship, or TS/SCP were provided. The oncologists and NPs 
jointly shared post treatment follow-up visits aligned with ASCO’s evidence based 
guidelines.  No written protocol outlining the oncology follow-up care existed to formally 
communicate with the patient or their providers. 
Benchmark and Evaluation 
Participants’ confidence in their knowledge of survivorship care was measured 
pre- and post visit using the Confidence In Survivorship Information (CSI) tool. It was 
anticipated improvement would occur for at least 80% of the women. The CSI tool is a 
validated, 13-item, 3-point Likert-type scale developed for this population. Three items 
measure survivors’ confidence in knowledge of diagnosis and treatment details; the 
reliability was established with a Cronbach’s alpha= 0.77.  The remaining 10 items, 
Cronbach’s alpha=0.95, measure confidence in prevention, late- and long-term effects of 
treatment and the cancer, prevention of future disease, familiar risk for cancer, and access 
to resources. Respondents rate each item as “not at all confident”,  “somewhat confident,” 
or “very confident”.21 
The benchmark for satisfaction, set at 80%, was measured using the Patient 
Satisfaction with Cancer-related Care (PSCC) tool. The PSCC is a validated tool of 18 
item with a 5-point Likert scale where “5=Strongly Agree and 1=Strongly Disagree”. It 
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demonstrates high construct validity, internal consistency, and reliability with diverse 
socioeconomic and cultural populations.22  
The provider satisfaction tool was investigator developed, designed to be 
answered in less then three minutes, and consisted of three question using a 5-point 
Likert scale. The goal was for 80% of the providers to agree/strongly agree the TS/SCP 
was easy to understand, useful in promoting effective patient care, and provided pertinent 
information.  
Implementation 
After obtaining IRB approval, the project was guided using the John Hopkins 
Nursing Evidence-Based Practice Model. The model has a practice process with three 
areas of focus: practice question, evidence, and translation (Figure 1). The practice 
question was initiated by the NPs at the site and supported by the oncologist and staff 
who actively participated in the design and execution of the program. A comprehensive 
review of the literature provided the evidence base and examples of numerous written 
and computerized templates in which TS/SCPs had been implemented in various 
oncology settings, both academic and community-based.  
Translation of the evidence into a working model began at the start of care. The 
Journey Forward Care Plan Builder© was downloaded onto the medical assistant (MA) 
and NP computers. A standard breast cancer survivorship template reflecting resources 
and practice patterns of the office was loaded onto a shared drive. At the time of the 
chemotherapy-teaching visit, the MA solicited the information to complete the 
demographic and care team portion of the TS/SCP. Using the pathology report, 
chemotherapy orders, and oncology consultation, the NP completed the background 
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information and treatment plan. An estimation of the date of completion of treatment was 
made and noted in a file. Each month the NP reviewed the progress of patients and a 50-
minute survivorship visit was scheduled for those completing treatment. Prior to the visit, 
the NP completed the remaining sections of the TS/SCP.  
On the day of the survivorship visit, participants received an explanation of the 
EBP project and were invited to participate in the pre/post evaluation process. 
Participants were given the opportunity to opt out of completing any or all parts of the 
evaluation. Participants electing to opt out still received the survivorship visit and 
personalized TS/SCP.  
During the visit, the NP reviewed the TS/SCP and the NCI booklet, Facing 
Forward: Life After Cancer Treatment. Input was solicited on lingering effects of 
treatment, questions answered, and referrals generated. Modifications were made based 
on participant’s input, and a revised hard copy was printed. The TS/SCP was scanned 
into the EMR and a personalized survivorship visit note was generated using a standard 
template. The PCP and care team were mailed a brief letter of explanation, the TS/SCP, 
provider survey, a self-addressed stamped envelope, and a $5.00 coffee gift card. Each 
provider was surveyed only once.  
Results 
During the evaluation period, 21 women participated in the practice innovation.  
Of the 26 providers who were mailed a TS/SCP, 19 (73%) returned the survey. Mean 
confidence in knowledge of cancer diagnosis/treatment details improved from 1.57 to 2.0. 
Similarly, mean confidence scores improved from .82 to 1.85 (t=8.66) in knowledge of 
prevention, late/long-term effects, resources, and familiar risk for cancer (Figure 2). 
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Improvement occurred for 100% of the participants. Satisfaction was rated at 4 or better 
for 95% of the women and 84% of providers’ agreed/strongly agreed with the elements of 
the survey (Figure 3). 
Economics 
An analysis of cost per visit was estimated. Average reimbursement by payer mix 
for a level five follow-up visit was obtained. Estimates of NP and the MA resources 
based on hourly rate to complete all parts of the project were subtracted from the average 
reimbursement. An additional $5.00 in cost was added to cover the printing of the NCI 
booklet. It was estimated that each visit generated approximately $25-$30 revenue.  
Discussion 
Arguably, there are far worse diseases then cancer, but few in which people 
associate so dramatically with suffering, pain, and premature death.  While feeling 
relatively well, the newly diagnosed cancer patient is thrust into a treatment plan that is 
difficult, lengthy, and potentially debilitating. Throughout the diagnosis and treatment, 
patients have numerous contacts with multiple healthcare providers. At the completion of 
treatment, this frequent contact suddenly, and abruptly, ceases. As previously stated, the 
literature on the residual physical, emotional, and psychosocial effects of cancer and its 
treatment is extensive. Therefore, it is paramount for the medical community to recognize 
the inherit anxiety emerging at the completion of primary cancer treatment and to 
embrace survivorship as a significant transition point.4  
At the conclusion of adjuvant cancer treatment, the questions and concerns of the 
cancer patient are different. As early apprehensions around treatment side effects and 
impact on lifestyle fade, new issues emerge. As this EBP project demonstrated, TS/SCP 
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and survivorship visits provide a similar impact at the end of treatment as chemotherapy 
teaching provides at the start.  Reduction in anxiety, fear, and confusion, increase in 
knowledge, and improvement in self-care recommendations are all outcomes of 
survivorship care supported in the literature.6,8,10–12  
 It is important to recognize aspects of this practice setting allowing the TS/SCP to 
be constructed at a reduced time and cost, than reported in the literature.7,23 By creating a 
standard template and populating more then 40% at the chemotherapy teaching session, 
the NP was able to save considerable time then might have been appreciated in practices 
where the TS/SCP is generated at the conclusion of treatment when the medical chart is 
more extensive. The NPs at this practice were familiar with the patients, their treatment, 
and problems they had encountered in the course of care. This proved advantageous, as 
the NP was able to complete the TS/SCP in an efficient manner that might not be possible 
in large practice or where the TS/SCP is produced in a dedicated survivorship clinic or by 
a different set of providers. A meaningful reduction in the high labor costs reported by 
other institutions was achieved by training the MAs to complete the data entry and 
incorporating a significant portion of the process into the existing workflow.  
While much of the literature on methods of delivering TS/SCP and survivorship 
care has originated from academic and large oncology centers, the vast majority of cancer 
patients receive the bulk of their treatment in community practices. For a large portion of 
patients who receive treatment with curative intent, their life as a survivor will be far 
longer then as an active cancer patient. It only makes sense, given this longevity, 
attention be given to the needs of this population. As this project demonstrated, it is 
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possible to not only to meet the requirements of the standards, but to provide value 
added, cost-effective care, that is meaningful to both patients and other providers.  
While the CSI tool measured the confidence the patient had in their knowledge, it 
did not measure the accuracy of this knowledge. While not measured in a scientific 
manner, during the review of the TS/SCP a number of participants discovered they had 
an incorrect understanding of their diagnosis and/or treatment. This was most frequently 
observed when reviewing the stage of cancer; patients often “up or down” staged their 
disease. This was further validated, as the pre/post improvement in this domain was not 
as robust as in the follow-up care domain. Kessels24 makes a salient point when stating 
that during an encounter, patients immediately forget 40-80% of medical information and 
50% of what is retained is erroneous. The more complex and/or distressing the 
information, the more likely the patient will remember it inaccurately.24 
 Patient education reduces anxiety and depression, promotes self-care and 
engagement, and has a positive effect on satisfaction, clinical outcomes, compliance, and 
quality of life in the adult patients with cancer.25–27 Furthermore, the use of written 
information improves the accuracy of recall of knowledge as well as demonstrating 
improvement in adherence to recommendations.24–27 It is also cost-effective.28 Given the 
length and complexity of cancer treatment the value of the TS/SCP and survivorship visit 
becomes even more vital as it represents an opportunity to correct inaccurate and 
erroneous information while educating on the next steps in care. 
As demonstrated in this project, the advanced practice registered nurse (APRN) is 
uniquely trained and positioned to provide survivorship care. Their role in symptom 
management and support during the acute phase of cancer treatment results in frequent 
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contact, allowing for understanding of the individual dynamics by which each patient and 
their family experience cancer. The holistic lens by which APRNs view the care of 
patients’ with serious illness, partnered with an education geared towards restoration of 
health and wellness, provides an ideal skill set for the provision of survivorship care.  
Conclusions 
TS/SCPs only fulfill one of the ten recommendations in the area of survivorship 
care outlined by the 2006 IOM report.  As new drugs and treatments, whose long-term 
side effects are still unknown, continue to expand the survivorship pool, the need to 
implement comprehensive survivorship care within community-based settings is crucial. 
The ability to provide curative cancer therapy is a noteworthy accomplishment worth 
celebrating. However, it is not enough if patients are left debilitated, vulnerable to other 
diseases, and with a poor quality of life. While transferring care to a dedicated 
survivorship clinic or a PCP is a viable and proven model, the value of the IOM’s 
direction “…This ‘Survivorship Care Plan’ should be written by the principle provider(s) 
who coordinated oncology treatment…4” cannot be understated. It is these providers who 
possess the knowledge to accurately set the course necessary to insure appropriate and 
comprehensive follow-up. 
The value of a TS/SCP is more pertinent then ever as our medical system remains 
one of ever evolving and expanding complexity. Compliance with accreditation standards 
and the IOM are the impetus for many organizations moving towards the provision of 
TS/SCPs. Yet, empowering patients with knowledge to participate in their own 
surveillance, risk reduction, and wellness, and improving the continuum of care, should 
be the driving force for oncology providers in expanding the scope and practice of 
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survivorship care. As the survivorship pool continues to grow, more research is needed to 
comprehensively address the unique and changing needs of the 21st century cancer 
patient. 
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Figure 1: Practice Model 
©The Johns Hopkins Hospital/The Johns Hopkins University
Used with permission 
 
 
Figure 2: Confidence In Survivorship Information
Question 1-3: Confidence in knowledge of past cancer diagnostics and treatment details
Question 4-10: Confidence in knowledge of prevention/treatment of late/long
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Purpose: The purpose of this evidence-based practice (EBP) project was to incorporate a 
treatment summary and survivorship care plan (TS/SCP) for women completing adjuvant 
treatment for breast cancer in a community-based oncology practice. 
 
Background:  Over the last three decades, advances in screening, diagnosis, and 
treatment have created an evolution in cancer care. In the United States it is estimated 12 
to 14 million people are survivors of cancer. Breast cancer survivors are a prominent 
subset, accounting for nearly 3.1 million survivors. The 2006 Institute of Medicine 
report; From Cancer Patient to Cancer Survivors: Lost In Transition identified 
survivorship as a distinct phase in the trajectory of cancer care and called attention to the 
significant gaps in the provision and coordination of care to this population. TS/SCP’s are 
a tool designed to improve outcomes, bridge the knowledge gap, decrease fragmentation 
of care, and increase satisfaction in the post treatment phase of cancer care. TS/SCP’s are 
incorporated into 43% of all National Cancer Institute (NCI) designated cancer centers. 
In the project facility, dedicated survivorship care was absent and there was no TS/SCP 
in use. 
Practice Innovation Process: The John Hopkins Nursing Evidence-Based Practice 
Model was used to guide this project. At the chemotherapy teaching visit, the Medical 
Assistant documented the demographic information of the TS/SCP into the Journey 
Forward Care Plan Builder. Using the pathology report, chemotherapy orders, and 
oncology consultation, the NP developed the TS/SCP in preparation for a 50-minute 
NP/patient survivorship visit.  A copy of the NCI publication: Facing Forward: Life After 
Cancer Treatment was reviewed and questions were addressed.  Knowledge was 
measured pre and post visit using the Confidence in Survivorship Information tool (CSI) 
while satisfaction was measured using the Patient Satisfaction with Cancer Care (PSCC) 
tool. A copy of the TS/SCP was provided to the patient and mailed to the treatment team 
and PCP, whose satisfaction was surveyed.  The project benchmark was for 80% of the 
participants to increase their knowledge and satisfaction with breast cancer survivorship 
care.  
 
Outcomes: All of the 21 participants, or 100%, who participated in the practice 
innovation had improvement in confidence in knowledge.  Specifically, knowledge of 
cancer diagnosis/treatment details improved from a mean average of 1.57 to 2.0 while 
knowledge of prevention, late/long-term effects, resources, and family risk for cancer 
increased from a mean average of 0.82 to 1.85.   Similarly, satisfaction increased for 95% 
of participants.  Of the 73% of providers who completed the survey, 84% agreed/strongly 
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agreed with the elements of the survey.  
Conclusions: TS/SCP delivered in the context of a dedicated survivorship visit with an 
NP consistently increases knowledge of all domains measured in the CSI tool. 
Satisfaction with the intervention was positive. As with many education and wellness 
interventions, the NP is uniquely qualified to support patients completing chemotherapy 
with curative intent as they transition to survivorship care. Furthermore, depending on 
payer mix, post treatment survivorship visits represent a potential revenue stream for a 
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Background 
• Of t he 14.5M Survivors, 3 .1M are Breast  
Cancer Survivors1,2
• Signif icant  gaps ident if ied in knowledge, 
provision, and coordinat ion of  care3
• Survivors report  
want ing more 
informat ion at  t he end 
of  Tx4
• Survivors experience 
residual physical/











• experience more chronic healt h 
problems/ co-morbidit ies t hen 
general populat ion3,4
• report  more t hen 25 problems, 
concerns, and needs af t er Tx3,5,6 ,7
• are at  risk for receiving inadequat e 
healt hcare4,8
• feel unprepared for end of  
t reatment 4,6,7
• report  high levels of  st ress and 
anxiet y3,4,6 ,9
Evidence 
• Treatment  summaries/ care plans are 
fundament al t o nursing and medical 
care
• Research shows signif icant  impact  wit h 
t he use of  int eract ive int ervent ions, 
writ t en informat ion, and 
psychoeducat ion10,11












In From Cancer Pat ient  t o Cancer 
Survivor: Lost  in Transit ion  t he 
IOM recommended TS/ SCP t o 
bridge gaps in survivorship care3
In Delivering High-Qualit y Cancer 
Care: Chart ing a New Course for a 
Syst em in Crisis, t he IOM 
reit erat ed t he need for TS/ SCP21
Benchmarks 
• Only 43% of  NCI cancer cent ers 
incorporat e TS/ SCPs for breast  and/ or 
colorect al cancer survivors18,22
• The Commission on Cancer, ASCO Qualit y 
Oncology Pract ice Init iat ive and t he 
Nat ional Accredit at ion Program for Breast  
Cent ers all have st andards requiring TS/
SCP23,24,25
• Dedicat ion survivorship care was absent  
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AIM: 
 Enhance knowledge and 
increase sat isfact ion for 
women complet ing adjuvant  
t reatment  for breast  cancer 
 Single NP direct ed   
survivorship visit
 Provision of  a 
personalized TS/ SCP
 Disseminat e t his informat ion t o 











80% of  part icipant s 
conf idence in 
knowledge of  
survivorship 
informat ion will 
improve as measured 
by pre/ post  scores on 
Conf idence in 
Survivorship 





How confident are you about your knowledge of each of the 
following aspects of your cancer and cancer related follow up care? 
 







The type of cancer you had?    
The stage of cancer you have/had?    
The treatments you received/are receiving for 
cancer? 
   
Things you can do to help prevent your cancer 
from recurring? 
   
The long-term physical effects you may 
experience from cancer and its treatment? 
   
Strategies for preventing long-term physical 
effects of cancer treatment? 
   
Strategies for treating long-term physical effects 
of cancer treatment? 
   
The long-term emotional effects you may 
experience from cancer and its treatment? 
   
Strategies for preventing long-term emotional 
effects of cancer treatment? 
   
Strategies for treating long-term emotional 
effects of cancer treatment? 
   
Community resources available to help you deal 
with long-term effects of cancer and its 
treatment? 
   
Whether your family members are at increased 
risk for cancer? 
   
How your family members can get information 
on their risk for cancer? 
   
 
Evaluation 
80% of  part icipant s 
overall sat isfact ion 
will rat e at  4  or 
bet t er on t he 
Pat ient  Sat isfact ion 






PLEASE RATE YOUR SATISFACTION WITH YOUR 






























































1. I felt my health concerns were understood     
 
2.  I felt that I was treated with courtesy and respect     
 
3.  I felt included in decisions about my health     
 
4.  I was told how to take care of myself     
 
5.  I felt encouraged to talk about my personal health concerns     
 
6.  I felt I had enough time with my provider     
 
7.  My questions were answered to my satisfaction     
 
8.  Making an appointment was easy     
 
9.  I knew what the next step in my care would be     
 
10. I felt confident in how I deal with the health care system     
 
11. I was able to get advice I needed about my health issues     
 
12. I knew who to contact when I had a question     
 
13. I received all the services I needed     
 
14. I am satisfied with the care I received     
 
15. The providers seem to communicate well about my care     
 
16. I received high quality care from my regular providers     
 
17. I received high quality care from my specialist     
 
18. My regular provider was informed about the results of the tests I 
got.  
    
 
 















80% of  providers 
will agree/ st rongly 
agree t hat  t he TS/
SCP was concise, 






















































1. The TS/SCP is easy to understand.      
2.  The TS/SCP is concise and provides pertinent 
information. 
     
3.  The TS/SCP will be a useful tool to promote 
effective patient care 










• TS/ SCPs were creat ed using 
t he Journey Forward Care Plan 
Builder
• Women at t ended an NP led 
survivorship visit
• Pre-visit  part icipant s 
complet ed t he CSI t ool
• The TS/ SCP and NCI 
publicat ion Facing Forward: 
Life Af t er Cancer are reviewed 
Facing Forward

























• Post -visit , part icipant s complet ed t he 
CSI Tool and PSCC Tool
• TS/ SCP was scanned int o t he EMR, 
survivorship visit  not e was creat ed, and 
referrals complet ed




• 21 women 
part icipat ed, 100% 
experienced 
improvement  
• Mean conf idence in 
knowledge Dx/ Tx 
det ails 1.57 t o 2 .0  
• Mean conf idence in 
knowledge prevent ion, 
lat e/ long-t erm ef fect s, 
resources, familiar risk



























• 26 providers were 
mailed surveys,19 were 
ret urned (73%)
• 84% of  providers 
agreed/ st rongly agreed 
wit h all element s of  t he 
survey
• 95% of  t he women 
rat ed sat isfact ion at  4  

















• Average reimbursement  for 
payer mix level 5  follow-up 
visit
• Subt ract ed est imat es of  
t ime/ cost  for NP and MA 
based on hourly rat es
• Addit ional $5.00 t o cover 
cost s of  NCI booklet










• CSI t ool only capt ured what  t he PTs 
conf idence was, not  if  t he knowledge was 
accurat e
• Unique aspect s of  t he pract ice set t ing 
allowing for signif icant  reduct ion in t ime/
cost s
• Cost s est imat ions were simplist ic and 
act ual revenue maybe more or less 
Practice Implications 
TS/ SCP and Survivorship visit s:
• Improve knowledge and ease t ransit ion
• Provide opport unit y for NP t o educat e: 
healt hy behaviors, risk reduct ion, assess 
impact  of  t reatment
• Engages PT in surveillance, 
risk reduct ion, wellness
• Serves as a road map 
clearly def ining EBP 
guidelines for follow-up 













• TS/ SCP provide similar impact  
at  t he end of  TX as chemo 
t eaching does at  t he beginning
• Pat ient s need/ benef it  f rom 
assessment , educat ion and 
goal set t ing at  t his junct ure
• TS/ SCP should be complet ed 
by t he principle providers 
• Survivorship care is pot ent ially 
revenue generat ing and can 
decrease healt hcare cost s 
Next Steps 
• Addit ion of  adjuvant  Colon Cancer by 
Summer 2015
• Explore int egrat ed EMR syst ems: OnQ, 
Varian Equicare CS
• Development  of  t imeline for addit ion of  all 
diagnoses in which adjuvant  t reatment  is 
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